Roflumilast Prescribing at HOLDERNESS HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
70
Total Quantity
2,080
NHS Cost
£2.5K
vs National Avg
+433.2%
HOLDERNESS HEALTH prescribed 70 items of Roflumilast over the last 12 months at a cost of £2,460 to the NHS. This is 433.2% above the national average prescribing rate. Roflumilast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
9
Jul 2026
6
Jul 2026
7
Jul 2026
5
Jul 2026
6
Jul 2026
8
Jul 2026
6
Jul 2026
4
Jul 2026
5
Jul 2026
5
Jul 2026
3
Jul 2026
6
Prescribing Details
| Total Items | 70 |
|---|---|
| Total Quantity | 2,080 |
| Total NHS Cost | £2,460 |
| Presentations | 3 different forms |
| vs National Average | +433.2% |
Roflumilast Prescribing Comparison
| This practice | 70 items |
|---|---|
| National average per practice | 13 items |
| Difference | +433.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.